NeoPharm Co Ltd
KOSDAQ:092730
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Springer Nature AG & Co KgaA
XETRA:SPG
|
DE |
|
F
|
Fad International Co SJSC
SAU:9589
|
SA |
|
Airgain Inc
NASDAQ:AIRG
|
US |
|
Grupo Mateus SA
BOVESPA:GMAT3
|
BR |
NeoPharm Co Ltd
Intangible Assets
NeoPharm Co Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
Intangible Assets
₩1.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
4%
|
|
|
AmorePacific Corp
KRX:090430
|
Intangible Assets
₩932B
|
CAGR 3-Years
55%
|
CAGR 5-Years
36%
|
CAGR 10-Years
18%
|
|
|
Amorepacific Group
KRX:002790
|
Intangible Assets
₩944.3B
|
CAGR 3-Years
54%
|
CAGR 5-Years
35%
|
CAGR 10-Years
17%
|
|
|
Cosmax Inc
KRX:192820
|
Intangible Assets
₩23.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Intangible Assets
₩1.1T
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Intangible Assets
₩189.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
31%
|
|
NeoPharm Co Ltd
Glance View
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2007-01-30. The firm produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. The company also engages in the original equipment manufacturing (OEM) of skin drugs.
See Also
What is NeoPharm Co Ltd's Intangible Assets?
Intangible Assets
1.8B
KRW
Based on the financial report for Sep 30, 2025, NeoPharm Co Ltd's Intangible Assets amounts to 1.8B KRW.
What is NeoPharm Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
4%
Over the last year, the Intangible Assets growth was -15%. The average annual Intangible Assets growth rates for NeoPharm Co Ltd have been -1% over the past three years , -6% over the past five years , and 4% over the past ten years .
